Lennar Confirms Expiration Date of Exchange Offer
Rhea-AI Summary
BD (NYSE:BDX) announced a pharmacy automation partnership with Henry Ford Health on Sept. 22, 2025 to develop a hospital and community pharmacy robotic solution using the BD Rowa Vmax.
The collaboration will pilot 24/7 prescription pickup, automated high-capacity storage and refrigerated handling, real-time prescription tracking, and modular scalability to improve pharmacy staff efficiency and ensure patients leave with medications in hand at discharge or clinic visits.
Positive
- None.
Negative
- None.
Insights
BD's partnership with Henry Ford Health to deploy the BD Rowa™ Vmax advances scalable pharmacy automation and patient access.
This collaboration links BD robotics to hospital-based community pharmacies, shifting routine dispensing to a high-capacity automated system and freeing staff for clinical tasks. The business mechanism is straightforward: install modular BD Rowa™ Vmax units to automate storage and retrieval, enable 24/7 patient pick-up, and add real-time tracking and refrigerated handling to expand service offerings.
Key dependencies and risks include successful technical integration with existing pharmacy workflows, reliable refrigerated handling for certain medications, and staff adoption of changed processes. Operational uptime and clear discharge workflows will determine whether patients actually leave with medicines in-hand.
Watch for pilot deployment metrics over the next 3–12 months, specifically changes in prescription retrieval time, staff task mix, and uptime/availability during off-hours. Early indicators of success will be operational reliability, patient uptake of 24/7 pickup, and measurable staff time reallocation within that timeframe.
Through this first-of-its-kind collaboration in the
"Modern pharmacy needs industrial-grade reliability and human-centered design. That's the driving force behind our High Value Pharmacy Enterprise — uniting every pharmacy touchpoint under one vision to deliver safer care, better access and measurable outcomes," said Jennifer Tryon, MS, FASHP, chief pharmacy officer at Henry Ford Health. "This partnership with BD advances that vision. By introducing this automation, we free our teams to focus on high-impact, patient-centered work. It's a bold step toward transforming how we serve our patients, our communities and our industry."
Widely used across
The partnership offers several key benefits, including:
- Use of automation to improve the overall community pharmacy experience
- Automated, high-capacity storage that safely and accurately retrieves patients' prescriptions while improving pharmacy staff efficiency, enabling them to focus on higher value patient care tasks
- 24/7 prescription access supports continuity of care and ensures convenience for patients
- Real-time prescription tracking and modular scalability
- Housing prescriptions, refrigerated medication, supplies and over-the-counter products patients may need for their ongoing care
"Henry Ford Health has one of the most innovative and patient-centered visions for what a health system pharmacy can do for patients," said Chad Glover, vice president and general manager of Pharmacy Automation at BD. "BD's robotics and pharmacy automation technologies are well aligned to support such a vision, and we are looking forward to this initial implementation as well as future collaborations to further advance Henry Ford Health's hospital and community pharmacies."
BD is working closely with Henry Ford Health to identify additional use cases for this automated pharmacy solution and other cutting-edge technologies, further reinforcing their shared commitment to health care innovation, improved clinical outcomes, and enhancing the patient experience.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
|
Contacts: |
|
|
|
|
|
Media: |
|
|
Fallon McLoughlin |
Magdalena Wegrzyn |
|
Director, Public Relations |
Senior Public Relations Specialist |
|
BD |
Henry Ford Health |
|
|
|
|
Investors: |
|
|
Adam Reiffe |
|
|
VP, Investor Relations |
|
|
BD |
|
|
201.847.6927 |
|
|
|
|
|
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-and-henry-ford-health-sign-pharmacy-automation-partnership-to-revolutionize-medication-storage-and-prescription-delivery-302561919.html
SOURCE BD (Becton, Dickinson and Company)